You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
九洲藥業(603456.SH):為進一步擴大CDMO產業規模 擬設立瑞博(台州)製藥
格隆匯 01-26 16:20

格隆匯 1 月 26日丨九洲藥業(603456.SH)公佈,公司為進一步擴大公司CDMO產業規模2021126日召開第董事會會議審議通過了《關於擬投資設立全資子公司的議案》同意公司以自有資金出資人民幣1億在浙江省臨海市頭門港經濟開發區投資設立全資子公司瑞博(台州)製藥有限公司(暫定名,以工商註冊登記為準)

根據公司整體戰略發展要求公司在浙江省臨海市頭門港經濟開發區設立瑞博(台州)製藥有限公司擴大研發、生產規模,進一步提升公司CDMO務一站式綜合服務能力此次設立的全資子公司納入公司合併報表範圍,目前尚處於建設初期,短期內不會對公司財務及經營狀況產生重大影響,且不存在損害上市公司及股東利益的情形。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account